172 items related to 'Burkina Faso'
(Page 2 of 9)
-
Our first year as an Independent Research Organisation
-
Resources: Presentation :
Estimating the impact of seasonal malaria chemoprevention: A modelling framework using routine data sources in Burkina Faso
Analysis of malaria prevalence data has demonstrated that seasonal malaria chemoprevention is having a significant impact in Burkina Faso.
-
Resources: Annual review :
Trustees' report and financial statements for the year to 31 March 2024
Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2024.
-
Resources: Journal article :
Using the role model approach to optimise caregiver administration of sulfadoxine-pyrimethamine amodiaquine to children aged 3–59 months in Burkina Faso, Chad and Togo
Caregivers perceived a role model approach to be helpful for improving drug administration during seasonal malaria chemoprevention. Effective promotion via community structures is recommended for…
-
Resources: Journal article :
Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: A qualitative exploration of caregivers and community distributors’ perspectives
In the context of increased adoption of SMC, this paper provides relevant insights and recommendations for the improved implementation of SMC programmes.
-
Malaria Consortium global capacity statement
-
Blog :
Pioneering solutions for community health: Africa's trailblazers
Many countries in Africa have grappled with significant challenges in providing accessible and quality healthcare to their populations due to insufficient infrastructure, shortages of medical…
-
Resources: Project brief :
Seasonal malaria chemoprevention
Malaria Consortium is a leading implementer of seasonal malaria chemoprevention (SMC) and carries out pioneering research to strengthen the quality and effectiveness of this life-saving intervention.
-
Resources: Poster :
Increasing certainty of seasonal malaria chemoprevention impact: A mathematical model using routine data in Burkina Faso
Age-related variations in routine data can be attributed to other interventions, non-malarial fevers and treatment-seeking, which mask the impact of seasonal malaria chemoprevention.
-
Resources: Capacity statement :
Global capacity statement
Our global capacity statement describes our approach and expertise and provides an overview of the key areas of our work.
-
Resources: Project report :
Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2023
This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2023.
-
Resources: Project report :
Malaria Consortium’s seasonal malaria chemoprevention programme: Philanthropy report 2023
This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC in 2023.
-
Resources: Annual review :
Trustees' report and financial statements for the year to 31 March 2023
Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2023.
-
completedEvaluating intermittent preventive treatment of malaria in school-aged children in Burkina Faso
While malaria outcomes are improving for pregnant women and children under five, malaria infection rates in Burkina Faso are rising, with 27 per cent of cases occurring in children aged 5-14 years.…
-
Resources: Project brief :
Evaluating intermittent preventive treatment of malaria in school-aged children in Burkina Faso
We are exploring new approaches to preventing malaria infections and reducing mortality in children aged between 5 and 14 years in Burkina Faso.
-
Resources: Presentation :
Malaria in older children and adolescents and the intermittent preventive treatment of malaria in school-aged children
Studies were conducted in Burkina Faso and Uganda to determine the malaria burden in school-age children and evaluate the implementation feasibility, efficacy, safety and cost-effectiveness of…
-
Resources: Annual review :
20 years of impact: Saving lives, transforming communities
On this, the 20th anniversary of Malaria Consortium, we reflect on the journey so far and provide insights into what we have achieved and how we seek to address the key challenges that remain.
-
Resources: Poster :
Resistance markers to sulfadoxine-pyrimethamine and amodiaquine in the context of seasonal malaria chemoprevention in Burkina Faso
Sulfadoxine-pyrimethamine and amodiaquine remain effective after eight years of SMC implementation in Burkina Faso.
-
Resources: Poster :
Analysing age-related trends in routine data through transmission modelling during seasonal malaria chemoprevention in Burkina Faso
Age-related variations in routine data can be attributed to non-malarial fevers and treatment-seeking behaviours, which mask the impact of seasonal malaria chemoprevention.
-
Resources: Poster :
Assessing the impact of extending seasonal malaria chemoprevention from four to five monthly cycles in Burkina Faso
Extending seasonal malaria chemoprevention from four to five cycles was associated with further reductions in malaria incidence and deaths in Burkina Faso.